"Two in five adult diabetic patients without cardiovascular disease in a national registry of cardiology outpatient practices were not prescribed a statin. Moreover, statin prescribing varied widely across these practices, US researchers report./"...
Humalog 75-25 Side Effects Center
Medical Editor: John P. Cunha, DO, FACOEP
Humalog Mix 75/25 [75% insulin lispro protamine suspension and 25% insulin lispro injection, (rDNA origin)] injection is a combination of two man-made insulins used to treat type 1 (insulin-dependent) or type 2 (non-insulin-dependent) diabetes. The combination of insulins in Humalog Mix 75/25 starts working faster and lasts for a longer time than regular insulin. Common side effects of Humalog Mix 75/25 include:
- low blood sugar (hypoglycemia)
- swelling of hands and feet
- injection site reactions (pain, redness, swelling, or itching)
- increased urination
- rapid breathing
- fruity breath odor
A side effect of too much insulin is low blood sugar (hypoglycemia), which includes symptoms such as:
- cold sweats
- blurred vision
- fast heartbeat
- tingling of the hands/feet
If any of these symptoms occur, tell your doctor immediately.
Dosage regimens of Humalog Mix 75/25 vary and are determined by the doctor familiar with the patient's metabolic needs, eating habits, and other lifestyle variables. Humalog Mix75/25 is intended only for subcutaneous administration. Humalog Mix75/25 may interact with medications with hyperglycemic activity such as corticosteroids, isoniazid, certain lipid-lowering drugs (e.g., niacin), estrogens, oral contraceptives, phenothiazines, and thyroid replacement therapy. Discuss with your doctor all medications and supplements you use. Tell your doctor if you are pregnant before using Humalog Mix 50/50. Discuss a plan for managing blood sugars with your doctor before becoming pregnant. Your doctor may switch the type of insulin you use during pregnancy. It is unknown if this drug passes into breast milk. Insulin needs may change while breastfeeding. Consult your doctor before breastfeeding.
Our Humalog Mix75/25 [75% insulin lispro protamine suspension and 25% insulin lispro injection, (rDNA origin)] Injection Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
What is Patient Information Overview?
A concise overview of the drug for the patient or caregiver from First DataBank.
Humalog 75-25 Overview - Patient Information: Side Effects
Pain, redness, swelling or itching at the injection site may occur. These effects usually go away after a few days or weeks. If any of these effects persist or worsen, notify your doctor or pharmacist promptly.
Remember that your doctor has prescribed this medication because he or she has judged that the benefit to you is greater than the risk of side effects. Many people using this medication do not have serious side effects.
Too much insulin can cause low blood sugar (hypoglycemia). This effect may also occur if you do not consume enough calories. The symptoms include chills, cold sweats, blurred vision, dizziness, drowsiness, shaking, fast heartbeat, weakness, headache, fainting, tingling of the hands/feet, or hunger. It is a good habit to carry glucose (sugar) tablets or gel to treat low blood sugar. If you don't have these reliable forms of glucose, raise your blood sugar quickly by eating a quick source of sugar such as table sugar, honey, candy, or drinking a glass of fruit juice or non-diet soda. Tell your doctor immediately about the reaction. To help prevent low blood sugar, eat meals on a regular schedule and do not skip meals.
Too little insulin can cause high blood sugar (hyperglycemia). Symptoms of high blood sugar include thirst, increased urination, confusion, drowsiness, flushing, rapid breathing, or fruity breath odor. If these symptoms occur, tell your doctor immediately. Your treatment plan may need to be changed.
This medication may cause low potassium levels in the blood (hypokalemia). Tell your doctor immediately if any of these unlikely but serious side effects occur: muscle cramps, weakness, irregular heartbeat.
A very serious allergic reaction to this drug is rare. However, seek immediate medical attention if you notice any of the following signs of a serious allergic reaction: rash, itching/swelling (especially of the face/tongue/throat), severe dizziness, trouble breathing.
This is not a complete list of possible side effects. If you notice other effects not listed above, contact your doctor or pharmacist.
In the US -
Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
In Canada - Call your doctor for medical advice about side effects. You may report side effects to Health Canada at 1-866-234-2345.
Read the entire patient information overview for Humalog 75-25 (75-25 Insulin Lispro Suspension and 25 Insulin Lispro Injection)
What is Prescribing information?
The FDA package insert formatted in easy-to-find categories for health professionals and clinicians.
Humalog 75-25 FDA Prescribing Information: Side Effects
Clinical studies comparing Humalog Mix75/25 with human insulin mixtures did not demonstrate a difference in frequency of adverse events between the two treatments.
Adverse events commonly associated with human insulin therapy include the following:
Body as a Whole - allergic reactions (see PRECAUTIONS).
Read the entire FDA prescribing information for Humalog 75-25 (75-25 Insulin Lispro Suspension and 25 Insulin Lispro Injection)
Additional Humalog 75-25 Information
Humalog 75-25 - User Reviews
Humalog 75-25 User Reviews
Now you can gain knowledge and insight about a drug treatment with Patient Discussions.
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
Find tips and advances in treatment.